www.wsj.com Open in urlscan Pro
2600:9000:223c:ee00:3:4b0:de80:93a1  Public Scan

Form analysis
1 forms found in the DOM

#

<form action="#" class="style--search-form-hI0pb2JfplZrewKUN--51 " role="search"><input id="searchInput" class="style--wsj-search-input-GNMy8Q5kg9IYwJKXYfIMm " placeholder="Enter News, Quotes, Companies or Videos" type="search"
    aria-label="Search the Wall Street Journal" tabindex="-1"><button class="style--search-submit-2EFgMYmHzRT8YBR7BYrV6G " aria-label="Submit Button" value="Search" type="submit" tabindex="-1">Search <svg width="24" height="24" viewBox="0 0 24 24">
      <defs>
        <path id="search-medium_svg__a" d="M10.5 2a7.5 7.5 0 015.645 12.438l5.365 5.365-.707.707-5.365-5.365A7.5 7.5 0 1110.5 2zm0 1a6.5 6.5 0 100 13 6.5 6.5 0 000-13z"></path>
      </defs>
      <use fill="currentColor" fill-rule="evenodd" xlink:href="#search-medium_svg__a"></use>
    </svg></button></form>

Text Content

Skip to Main ContentSkip to SearchSkip to...
Select
 * Listen to Article
 * What To Read Next
 * Opinion Editor's Picks
 * Sponsored Offers
 * Most Popular News
 * Most Popular Opinion
 * Opinion Editor's Picks
 * Recommended Videos

Dow Jones, a News Corp companyAbout WSJ
 * News Corp is a global, diversified media and information services company
   focused on creating and distributing authoritative and engaging content and
   other products and services.
 * Dow Jones
   * Barron's
   * BigCharts
   * Dow Jones Businesses
   * Dow Jones Newswires
   * Factiva
   * Financial News
   * Mansion Global
   * MarketWatch
   * Newsmart
   * NewsPlus
   * Risk & Compliance
   * WSJ Live
   * WSJ Pro
   * WSJ Video
   * WSJ.com
 * News Corp
   * Avail
   * Business Spectator
   * HarperCollins Publishers
   * Housing
   * Makaan
   * New York Post
   * REA
   * realtor.com
   * Storyful
   * The Australian
   * The Sun
   * The Times
 * 


DJIA Futures33167 points with a0.41%▲
S&P 500 F4188.75 points with a0.47%▲
Stoxx 600444.18 points with a0.45%▼
U.S. 10 Yr1/32 Yieldwith a2.959%▲
Crude Oil106.68 points with a4.17%▲
Euro1.0527 points with a0.07%▲
The Wall Street Journal
SubscribeSign In
Special Offer
The Wall Street Journal
€2 per Month for 1 Year
Get the insights and analysis trusted by key decision-makers around the world.
Become a WSJ Member Today
View Membership Options

English Edition
 * English
 * 中文 (Chinese)
 * 日本語 (Japanese)

Print Edition
Video
Podcasts
Latest Headlines
SubscribeSign In

 * Home
 * World
   
   REGIONS
   
    * Africa
    * Asia
    * Canada
    * China
    * Europe
    * Latin America
    * Middle East
   
   SECTIONS
   
    * Economy
   
   MORE
   
    * World Video

 * U.S.
   
   SECTIONS
   
    * Economy
    * Law
    * Politics
   
   MORE
   
    * WSJ Noted.
    * U.S. Video
    * What's News Podcast

 * Politics
   
   SECTIONS
   
    * Capital Journal
   
   MORE
   
    * Politics Video
   
   COLUMNS
   
    * Gerald Seib
    * Washington Wire

 * Economy
   
   WSJ PRO
   
    * Bankruptcy
    * Central Banking
    * Private Equity
    * Strategic Intelligence
    * Venture Capital
   
   MORE
   
    * Economic Forecasting Survey
    * Economy Video
   
   SECTIONS
   
    * Capital Account

 * Business
   
   SECTIONS
   
    * Management
    * The Future of Everything
    * Obituaries
    * Tech/WSJ.D
   
   INDUSTRIES
   
    * Aerospace & Defense
    * Autos & Transportation
    * Commercial Real Estate
    * Consumer Products
    * Energy
    * Entrepreneurship
    * Financial Services
    * Food & Services
    * Health Care
   
    * Hospitality
    * Law
    * Manufacturing
    * Media & Marketing
    * Natural Resources
    * Retail
   
   C-SUITE
   
    * CFO Journal
    * CIO Journal
    * CMO Today
    * Logistics Report
    * Risk & Compliance
    * The Workplace Report
   
   COLUMNS
   
    * Heard on the Street
   
   WSJ PRO
   
    * Bankruptcy
    * Central Banking
    * Cybersecurity
    * Private Equity
    * Sustainable Business
    * Venture Capital
   
   MORE
   
    * Business Video
    * Journal Report
    * Business Podcast
    * Space & Science

 * Tech
   
   SECTIONS
   
    * CIO Journal
    * The Future of Everything
    * Personal Tech
   
   COLUMNS
   
    * Christopher Mims
    * Joanna Stern
    * Julie Jargon
    * Nicole Nguyen
   
   MORE
   
    * Tech Video
    * Tech Podcast

 * Markets
   
   SECTIONS
   
    * Bonds
    * Commercial Real Estate
    * Commodities & Futures
    * Stocks
    * Personal Finance
    * WSJ Money
    * Streetwise
    * Intelligent Investor
   
   COLUMNS
   
    * Heard on the Street
    * Greg Ip
    * Jason Zweig
    * Laura Saunders
    * James Mackintosh
   
   MARKET DATA
   
    * Market Data Home
    * U.S. Stocks
    * Currencies
    * Companies
    * Commodities
    * Bonds & Rates
    * Mutual Funds & ETFs
   
   MORE
   
    * CFO Journal
    * Markets Video
    * Your Money Briefing Podcast
    * Secrets of Wealthy Women Podcast
   
   Search Quotes and Companies
 * Opinion
   
   COLUMNISTS
   
    * Gerard Baker
    * Sadanand Dhume
    * James Freeman
    * William A. Galston
    * Daniel Henninger
    * Holman W. Jenkins
    * Andy Kessler
    * William McGurn
    * Walter Russell Mead
    * Peggy Noonan
    * Mary Anastasia O'Grady
    * Jason Riley
    * Joseph Sternberg
    * Kimberley A. Strassel
   
   MORE
   
    * Editorials
    * Commentary
    * Future View
    * Letters to the Editor
    * The Weekend Interview
    * Potomac Watch Podcast
    * Foreign Edition Podcast
    * Free Expression Podcast
    * Opinion Video
    * Notable & Quotable

 * Books & Arts
   
   REVIEWS
   
    * Film
    * Television
    * Theater
    * Masterpiece Series
    * Music
    * Dance
    * Opera
    * Exhibition
    * Cultural Commentary
   
   SECTIONS
   
    * Arts
    * Books
   
   MORE
   
    * WSJ Puzzles
    * Life Video
    * Arts Video

 * Real Estate
   
   SECTIONS
   
    * Commercial Real Estate
   
   MORE
   
    * Real Estate Video

 * Life & Work
   
   SECTIONS
   
    * Cars
    * Careers
    * Entertainment
    * Food & Drink
    * Home & Design
    * Ideas
    * Personal Finance
    * Recipes
    * Style & Fashion
    * Travel
    * Wellness
   
   COLUMNS
   
    * Your Health
    * Work & Life
    * The Middle Seat
    * Bonds
    * At Work
    * Turning Points
    * Off Brand
    * On Trend
    * On Wine
    * On The Clock
   
   MORE
   
    * WSJ Puzzles
    * Space & Science

 * WSJ. Magazine
   
   SECTIONS
   
    * Fashion
    * Art & Design
    * Travel
    * Food
    * Culture

 * Sports
   
   SECTIONS
   
    * Beijing 2022 Olympics
    * MLB
    * NBA
    * NFL
    * Golf
    * Tennis
    * Soccer
   
   COLUMNS
   
    * Jason Gay

Search
 * Home
 * World
   
   REGIONS
   
    * Africa
    * Asia
    * Canada
    * China
    * Europe
    * Latin America
    * Middle East
   
   SECTIONS
   
    * Economy
   
   MORE
   
    * World Video

 * U.S.
   
   SECTIONS
   
    * Economy
    * Law
    * Politics
   
   MORE
   
    * WSJ Noted.
    * U.S. Video
    * What's News Podcast

 * Politics
   
   SECTIONS
   
    * Capital Journal
   
   MORE
   
    * Politics Video
   
   COLUMNS
   
    * Gerald Seib
    * Washington Wire

 * Economy
   
   WSJ PRO
   
    * Bankruptcy
    * Central Banking
    * Private Equity
    * Strategic Intelligence
    * Venture Capital
   
   MORE
   
    * Economic Forecasting Survey
    * Economy Video
   
   SECTIONS
   
    * Capital Account

 * Business
   
   SECTIONS
   
    * Management
    * The Future of Everything
    * Obituaries
    * Tech/WSJ.D
   
   INDUSTRIES
   
    * Aerospace & Defense
    * Autos & Transportation
    * Commercial Real Estate
    * Consumer Products
    * Energy
    * Entrepreneurship
    * Financial Services
    * Food & Services
    * Health Care
   
    * Hospitality
    * Law
    * Manufacturing
    * Media & Marketing
    * Natural Resources
    * Retail
   
   C-SUITE
   
    * CFO Journal
    * CIO Journal
    * CMO Today
    * Logistics Report
    * Risk & Compliance
    * The Workplace Report
   
   COLUMNS
   
    * Heard on the Street
   
   WSJ PRO
   
    * Bankruptcy
    * Central Banking
    * Cybersecurity
    * Private Equity
    * Sustainable Business
    * Venture Capital
   
   MORE
   
    * Business Video
    * Journal Report
    * Business Podcast
    * Space & Science

 * Tech
   
   SECTIONS
   
    * CIO Journal
    * The Future of Everything
    * Personal Tech
   
   COLUMNS
   
    * Christopher Mims
    * Joanna Stern
    * Julie Jargon
    * Nicole Nguyen
   
   MORE
   
    * Tech Video
    * Tech Podcast

 * Markets
   
   SECTIONS
   
    * Bonds
    * Commercial Real Estate
    * Commodities & Futures
    * Stocks
    * Personal Finance
    * WSJ Money
    * Streetwise
    * Intelligent Investor
   
   COLUMNS
   
    * Heard on the Street
    * Greg Ip
    * Jason Zweig
    * Laura Saunders
    * James Mackintosh
   
   MARKET DATA
   
    * Market Data Home
    * U.S. Stocks
    * Currencies
    * Companies
    * Commodities
    * Bonds & Rates
    * Mutual Funds & ETFs
   
   MORE
   
    * CFO Journal
    * Markets Video
    * Your Money Briefing Podcast
    * Secrets of Wealthy Women Podcast
   
   Search Quotes and Companies
 * Opinion
   
   COLUMNISTS
   
    * Gerard Baker
    * Sadanand Dhume
    * James Freeman
    * William A. Galston
    * Daniel Henninger
    * Holman W. Jenkins
    * Andy Kessler
    * William McGurn
    * Walter Russell Mead
    * Peggy Noonan
    * Mary Anastasia O'Grady
    * Jason Riley
    * Joseph Sternberg
    * Kimberley A. Strassel
   
   MORE
   
    * Editorials
    * Commentary
    * Future View
    * Letters to the Editor
    * The Weekend Interview
    * Potomac Watch Podcast
    * Foreign Edition Podcast
    * Free Expression Podcast
    * Opinion Video
    * Notable & Quotable

 * Books & Arts
   
   REVIEWS
   
    * Film
    * Television
    * Theater
    * Masterpiece Series
    * Music
    * Dance
    * Opera
    * Exhibition
    * Cultural Commentary
   
   SECTIONS
   
    * Arts
    * Books
   
   MORE
   
    * WSJ Puzzles
    * Life Video
    * Arts Video

 * Real Estate
   
   SECTIONS
   
    * Commercial Real Estate
   
   MORE
   
    * Real Estate Video

 * Life & Work
   
   SECTIONS
   
    * Cars
    * Careers
    * Entertainment
    * Food & Drink
    * Home & Design
    * Ideas
    * Personal Finance
    * Recipes
    * Style & Fashion
    * Travel
    * Wellness
   
   COLUMNS
   
    * Your Health
    * Work & Life
    * The Middle Seat
    * Bonds
    * At Work
    * Turning Points
    * Off Brand
    * On Trend
    * On Wine
    * On The Clock
   
   MORE
   
    * WSJ Puzzles
    * Space & Science

 * WSJ. Magazine
   
   SECTIONS
   
    * Fashion
    * Art & Design
    * Travel
    * Food
    * Culture

 * Sports
   
   SECTIONS
   
    * Beijing 2022 Olympics
    * MLB
    * NBA
    * NFL
    * Golf
    * Tennis
    * Soccer
   
   COLUMNS
   
    * Jason Gay

Search
Search






https://www.wsj.com/articles/cerebrals-preferred-pharmacy-truepill-halts-adderall-prescriptions-for-all-customers-11651504078


Share
 * Facebook
 * Twitter
 * LinkedIn
 * Copy Link

 * WSJ News Exclusive
 * Health


CEREBRAL’S PREFERRED PHARMACY TRUEPILL HALTS ADDERALL PRESCRIPTIONS FOR ALL
CUSTOMERS


ONLINE PHARMACY STARTUP SAYS IT IS TEMPORARILY PAUSING SCHEDULE 2 DRUGS ‘OUT OF
AN ABUNDANCE OF CAUTION’

The Wall Street Journal
Continue reading your article with a WSJ membership.
Special Offer
€2 per Month for 1 Year
View Membership Options


TRUEPILL SAID SCHEDULE 2 CONTROLLED SUBSTANCES SUCH AS ADDERALL MAKE UP LESS
THAN 1% OF ITS TOTAL PRESCRIPTION VOLUME.

Photo: Kristoffer Tripplaar/Sipa/Associated Press
By
Rolfe Winkler
Updated May 2, 2022 2:28 pm ET

Print

Text

Your browser does not support the audio tag.
Listen to article
Length (5 minutes)
AD
Loading advertisement...
00:00 / 05:06
1x

This article is in your queue.
Open Queue

Online pharmacy company Truepill Inc. said it is temporarily halting
prescriptions for Adderall and other controlled substances used to treat
attention-deficit hyperactivity disorder, and partner Cerebral Inc. told its
clinicians to direct those orders to patients’ local pharmacies.

Cerebral, an online mental-health company based in San Francisco that describes
Truepill as its preferred pharmacy, informed its clinicians of Truepill’s
decision in a Friday email viewed by The Wall Street Journal. The email said
Truepill would no longer support mailing Schedule 2 controlled substances,
including Adderall and Vyvanse, “to any of their customers.”

Truepill said that, “out of an abundance of caution,” it is temporarily pausing
all fulfillment of Schedule 2 substances while it evaluates appropriate next
steps. It said Schedule 2 substances such as Adderall make up less than 1% of
its total prescription volume. Truepill didn’t provide a list of other partners
affected by its decision.

Some of the nation’s largest pharmacies have blocked or delayed prescriptions
over the past year from clinicians working for telehealth startups that have
sprung up to treat ADHD, according to pharmacies and people familiar with the
issue.



The Journal reported last week that pharmacies including Walmart Inc., CVS
Health Corp. and Walgreens Boots Alliance Inc. have blocked or delayed
prescriptions for companies treating ADHD online or have blocked individual
prescribers, according to people familiar with the issue.

Walmart confirmed it has blocked some prescribers and some prescriptions. A
spokesman for Walgreens outlined the company’s prescribing practices but
wouldn’t discuss the decision to block prescriptions. A CVS spokesman said its
controlled-substance compliance group interviews clinicians it flags for
potentially excessive prescribing practices.

Truepill is going further by stopping indefinitely all prescriptions of Adderall
and other Schedule 2 controlled substances.

Cerebral said in the email to clinicians Friday that Truepill would continue
filling other prescriptions, including for Schedule 3 through 5 controlled
substances that the federal government designates as having lower potential for
abuse.

The government classifies Schedule 2 substances as drugs “with a high potential
for abuse, with use potentially leading to severe psychological or physical
dependence.” Other Schedule 2 substances include OxyContin and Vicodin.

At the same time, stimulants such as Adderall can have significant benefits for
people properly diagnosed with ADHD, psychiatrists say.

--------------------------------------------------------------------------------

NEWSLETTER SIGN-UP

CORONAVIRUS BRIEFING AND HEALTH WEEKLY

Get a weekly briefing about the coronavirus pandemic and a Health newsletter
when the crisis abates.

PREVIEW
SUBSCRIBE

--------------------------------------------------------------------------------

Cerebral said it is working with Truepill “to ensure a smooth transition for
impacted clients and prevent a disruption in the client’s prescribed,
evidence-backed course of treatment.” It said Truepill’s action affects less
than 2% of its total prescriptions.

Some nurse practitioners at Cerebral say they have felt pressured to prescribe
stimulants like Adderall, and say the companies’ 30-minute evaluations aren’t
long enough to properly diagnose ADHD, the Journal reported in March.

“We do not pressure our clinicians and have not disciplined, reprimanded or
dismissed a clinician for not prescribing medications,” Cerebral said. “We have
a multistep approach to assessing our clients and provide our clinicians with
the support to make the best decisions on behalf of their patients.”

Truepill is a mail-order pharmacy startup based in California that sends out
medications prescribed by other telehealth companies. It was valued at $1.6
billion in a private funding round last fall, according to research firm
PitchBook Data Inc.

Cerebral was valued at $4.8 billion in a late 2021 funding round, according to
PitchBook.

Cerebral has encouraged its clinicians to fill prescriptions through Truepill,
describing it internally as its “preferred pharmacy,” according to documents
viewed by the Journal. Truepill then ships those medications in Cerebral-branded
boxes. Cerebral includes a section on clinicians’ employee-feedback page that
tracks the percentage of prescriptions they send to Truepill versus local
pharmacies, according to people familiar with Cerebral’s prescribing practices
and a copy of a feedback page viewed by the Journal.

Cerebral recognizes as revenue sales of prescriptions that go through Truepill,
boosting Cerebral’s top-line growth rate, according to a person familiar with
the company’s operations.

Cerebral said clients choose which pharmacy they want to fill their
prescriptions. It declined to comment on its financial arrangement with
Truepill. Truepill also declined to comment on Cerebral’s business practices.

Last month Truepill said it would shut down a subsidiary called Ahead that
offered ADHD treatment online and competed directly with Cerebral.

Write to Rolfe Winkler at rolfe.winkler@wsj.com

Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved.
87990cbe856818d5eddac44c7b1cdeb8



Appeared in the May 3, 2022, print edition as 'Truepill To Stop Providing
Adderall.'




Sponsored Offers
 * Wayfair:
   Extra 15% off + free shipping at Wayfair
 * TurboTax:
   Save up to an additional $15 with TurboTax May 2022
 * H&R Block Tax:
   H&R Block Tax Sale - Up to 20% off tax software
 * Target:
   Up to 60% off - Target Promo Code
 * Macy's:
   Macy's coupon - Sign up to get 25% off next order




MOST POPULAR NEWS

 * THEY KEPT PAYING WHEN STUDENT LOAN DEBT PAUSED

 * WHERE STATE ABORTION LAWS STAND IF ROE V. WADE IS OVERTURNED

 * STOCKS, BONDS FALL IN LOCKSTEP AT PACE UNSEEN IN DECADES

 * NFT SALES ARE FLATLINING

 * CEREBRAL’S PREFERRED PHARMACY TRUEPILL HALTS ADDERALL PRESCRIPTIONS FOR ALL
   CUSTOMERS


MOST POPULAR OPINION

 * OPINION: ELON MUSK TWEETED MY CARTOON

 * OPINION: THE SUPREME COURT LEAK ON ROE V. WADE

 * OPINION: POPE FRANCIS BLAMES NATO

 * OPINION: STUDENT LOAN TRUTH TELLING

 * OPINION: SHUT UP, THE DISINFORMATION GOVERNANCE BOARD EXPLAINED




RECOMMENDED VIDEOS

 * EU ANTITRUST CHIEF: APPLE ‘ABUSED’ MOBILE-PAYMENT MARKET POWER

 * MISSILES HIT KYIV DURING U.N. CHIEF VISIT; HOUSE PASSES ‘LEND-LEASE’ BILL

 * U.S. GAS PRODUCERS UNDER PRESSURE AS RUSSIA CUTS OFF SUPPLIES IN EUROPE

 * ZELENSKY ON THE HORRORS OF WAR IN UKRAINE

 * PELOSI MEETS WITH ZELENSKY, VOWS SUPPORT FOR UKRAINE ‘UNTIL THE FIGHT IS
   DONE’














 * The Wall Street Journal
 * 
   English Edition
    * English
    * 中文 (Chinese)
    * 日本語 (Japanese)

 * * Subscribe Now
   * Sign In
 * Back to Top «

WSJ Membership

 * WSJ+ Membership Benefits
 * Subscription Options
 * Why Subscribe?
 * Corporate Subscriptions
 * Professor Journal
 * Student Journal
 * WSJ High School Program
 * Public Library Program
 * WSJ Live

Customer Service

 * Customer Center
 * Contact Us

Tools & Features

 * Newsletters & Alerts
 * Guides
 * Topics
 * My News
 * RSS Feeds
 * Video Center
 * Watchlist
 * Podcasts
 * Visual Stories

Ads

 * Advertise
 * Commercial Real Estate Ads
 * Place a Classified Ad
 * Sell Your Business
 * Sell Your Home
 * Recruitment & Career Ads
 * Coupons
 * Digital Self Service

More

 * About Us
 * Commercial Partnerships
 * Content Partnerships
 * Corrections
 * Jobs at WSJ
 * News Archive
 * Register for Free
 * Reprints & Licensing
 * Buy Issues
 * WSJ Shop

 * Facebook
 * Twitter
 * Instagram
 * YouTube
 * Podcasts
 * Snapchat
 * Google Play
 * App Store

Dow Jones Products

 * Barron's
 * BigCharts
 * Dow Jones Newswires
 * Factiva
 * Financial News
 * Mansion Global
 * MarketWatch
 * Risk & Compliance
 * WSJ Pro
 * WSJ Video
 * WSJ Wine

 * Privacy Notice
 * Cookie Notice
 * Copyright Policy
 * Data Policy
 * Subscriber Agreement & Terms of Use
 * Your Ad Choices
 * Accessibility
 * Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved.







Copyright © 2022 Dow Jones & Company, Inc. All Rights Reserved